1 / 28

Complications of Menopause

Complications of Menopause. Jianhong Zhou. Women’s Hospital, School of Medicine, Zhejiang University. First Part. Definition. Definition. Menopause is defined by 12 months of amenorrhea after the final menstrual period (FMP).

kearneym
Download Presentation

Complications of Menopause

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Complications of Menopause Jianhong Zhou Women’s Hospital, School of Medicine, Zhejiang University

  2. First Part Definition

  3. Definition Menopause is defined by 12 monthsof amenorrhea after the final menstrual period (FMP). The average age of menopause is 51.4 years, with 90% becoming menopausal between the ages of 45 to 55 years of age. Premature menopauseis defined as the permanent cessation of menses occurring before 40 years of age.

  4. Various physiologic and hormonal changes occur • A decrease in estrogen • Increase in FSH • Classic symptoms such as • Hot flashes • Night sweats • Mood swings • Vaginal dryness

  5. How often and serious ? 50% 10% of women will begin during perimenopause will experience an increase in symptoms during menopause Symptoms may last during the first year or two of menopause Rarely do symptoms extend beyond the first 5 years of menopause

  6. Second Part Etiology

  7. Etiology Menopause is heralded by menstrual irregularityas the number of oocytes capable of responding to FSH and LH decreases A Anovulation becomes more frequent B C LHandFSHlevels gradually rise because of decreased negative feedback from diminished E production

  8. Inhibin Estradiol Hypothalamus Pituitary gland Ovary=No gonadal E FSH,LH FSH,LH Norepinephrine Dopamine Prostaglandins Uterus Vagina Breast Bone Cardiovascular system Hot flashes Insomnia Depression Osteoporosis Atherosclerosis Atrophy

  9. Third Part Diagnosis

  10. Diagnosis [C] Confirmed by testing FSH levels [A] History [B] Physical exam

  11. Diagnosis -History • Average age of 51 • Complaining of amenorrhea, vasomotor instability, sweats, mood changes, depression, dyspareunia, and dysuria • Disappear within 12 months generally • Remain for years

  12. Diagnosis-PE • Decrease in breast size and change in texture • Vaginal, urethral, cervical atrophy • Be consistent with decreased E

  13. Diagnosis-FSH • If there is any question about the diagnosis, an elevated FSH is diagnostic of menopause • During the perimenopausal period, the FSH level may be increased or decreased • FSH is best reserved for patients with a combination of amenorrhea or oligomenorrhea and menopausal symptoms

  14. Fourth Part Pathogenesis

  15. Pathogenesis • Long-term consequences of the estrogen decrease • Osteoporosis -bone resorption accelerates • Atherosclerosis • increased risk for coronary artery disease

  16. Osteoporosis

  17. coronary artery disease

  18. Fifth Part Therapy

  19. Therapy HRT and ERT A C B The E component on HRT supplies the patient with an exogenous source of E and thereby treats the symptoms of menopause HRT –hormone replacement therapy-refers to the use of a combination of estrogen and progesterone to treat menopausal related symptoms in women who still have their uterus in situ Menopausal symptoms are due to decreased E levels

  20. Therapy HRT and ERT can be used for women with menopausal symptoms who have undergone a hysterectomy HRT ERT Progestins must be used to decrease the risk of endometrial hyperplasia and cancer in women who still have a uterus in situ Unopposed estrogen exposure can result in endometrial hyperplasia or cancer

  21. Therapy HRT and ERT • The other major value of HRT is the prevention and treatment of osteoporosis • A important preventative measure—since 15% of women over age 50 will be diagnosed with osteoporosis and 50% with osteopenia • A woman can lose 20% of her original bone density in the first 5 to 7 years after menopause

  22. Therapy HRT and ERT • The risks and benefits have been the center of numerous studies over the past few decades • Each patient’s symptoms, risk factors, and related risks and benefits should be individually evaluated

  23. Therapy Contraindications to HRT • Chronic liver impairment • Pregnancy • Known estrogen-dependent neoplasm • Breast cancer • History of thromboembolic disease • Undiagnosed vaginal bleeding • Porphyrias • Meningioma

  24. Therapy Additional therapeutic regimens • Alternative regimens for postmenopausal women who are unable or unwilling to take HRT, should be targeted toward the individual’s symptoms and treatment goals • Vasomotor flushes • Vaginal atrophy • The prevention and treatment for osteoporosis

  25. Therapy How to treat vasomotor flushes • Be managed with clonidine • Selective serotonin reuptake inhibitors (SSRIs) • Antidepressants (SSRIs/SNRIs) • Gabapentin • Clonidine • Isoflavones, red clover, black cohosh • Cognitive behavior therapy • Acupuncture • Stellate ganglion block

  26. Therapy How to treat vaginal atrophy • Locally use with lubricants and moisturizers • Vaginal estrogen with only minimal systemicabsorption

  27. Therapy Prevention and treatment for osteoporosis • Calcium and vitamin D supplementation • Calcitonin • Raloxifene • Weight-bearing exercise • Reduction in smoking and in caffeine and alcohol intake

  28. THANK YOU FOR YOUR ATTENTION • 参考 • 八年制教材 • 中华绝经学组围绝经期诊治指南（2012） • Postmenopausal Hormone Therapy（An Endocrine Society Scientific Statement 2010) • 国际绝经协会关于绝经后激素治疗和中年女性健康预防策略的最新建议（2016）

More Related